IAVI 011

Randomized, Placebo-Controlled, Dosage-Escalating Phase 1 Study, Double-Blinded with Respect to Assignment to either Vaccine or Placebo, to Evaluate the Safety and Immunogenicity of a Modified Vaccinia virus Ankara Vaccine containing the Clade A HIV-1 gag gene, (MVA HIVA) Vaccine Administered by Three Different Routes and at Three Different Dosage Levels in HIV-Uninfected, Healthy Volunteers.

Trial Details:

I Completed
International AIDS Vaccine Initiative (IAVI), South African Aids Vaccine Initiative (SAAVI) November 01, 2003
MVA.HIVA Viral Vector - Pox
South Africa, Switzerland, United Kingdom 81